Lineage Cell Therapeutics (LCTX) Goodwill & Intangibles (2010 - 2026)
Lineage Cell Therapeutics (LCTX) posted Goodwill & Intangibles of $42.37 million for Q2 2026, unchanged from $42.37 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Since Q4 2010, Lineage Cell Therapeutics has reported Goodwill & Intangibles for 62 quarters.
- Annual Goodwill & Intangibles shows a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
- In prior years, Lineage Cell Therapeutics' Goodwill & Intangibles was $57.21 million in FY2024 (unchanged), $57.23 million in FY2023 (-0.2%), $57.36 million in FY2022 (-0.2%) and $57.49 million in FY2021 (-0.4%).
- Quarterly Goodwill & Intangibles has run from a low of $42.37 million in Q2 2025 to a high of $57.53 million in Q3 2021 over five years.
- Over the past five years, the year-over-year decline in Goodwill & Intangibles ranged from 0.0% (Q2 2026) to 25.9% (Q2 2025).
- According to Business Quant data, Goodwill & Intangibles for the three prior quarters was $42.37 million (Q1 2026), $42.37 million (Q4 2025) and $42.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 227.62 Mn | 26.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.37 Mn |
| Mar 31, 2026 | 42.37 Mn |
| Dec 31, 2025 | 42.37 Mn |
| Sep 30, 2025 | 42.37 Mn |
| Jun 30, 2025 | 42.37 Mn |
| Mar 31, 2025 | 57.21 Mn |
| Dec 31, 2024 | 57.21 Mn |
| Sep 30, 2024 | 57.21 Mn |
| Jun 30, 2024 | 57.21 Mn |
| Mar 31, 2024 | 57.21 Mn |
| Dec 31, 2023 | 57.23 Mn |
| Sep 30, 2023 | 57.27 Mn |
| Jun 30, 2023 | 57.30 Mn |
| Mar 31, 2023 | 57.33 Mn |
| Dec 31, 2022 | 57.36 Mn |
| Sep 30, 2022 | 57.40 Mn |
| Jun 30, 2022 | 57.43 Mn |
| Mar 31, 2022 | 57.46 Mn |
| Dec 31, 2021 | 57.49 Mn |
| Sep 30, 2021 | 57.53 Mn |
API Access
Lineage Cell Therapeutics Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();